We are exploring the commercialization and development of a versatile breathalyzer system. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath, measured in concentration units (ppm, parts-per-million), so the user knows their real-time ketosis status.
The breathalyzer is registered with the United States FDA as a Class I medical device (US FDA registration #3026284320).
We are focused on bringing forward intellectual property through joint patent filings with the Massachusetts Institute of Technology (MIT), led by Professor Shuguang Zhang as Principal Investigator.
Using the unique QTY code protein design platform, six water-soluble variant cytokine receptors have been successfully designed and tested to show binding affinity to the respective cytokines. We are currently focused on advancing the intellectual property associated with this program through joint patent submissions.